10-K Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001564590-22-008045`
Period End Date	20211231
Filing Date	20220301
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	tmdx-10k_20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 34 Cash Flow Statement 69 Stockholders Equity 21 Comprehensive Income 12

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.79M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.18M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.58M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.58M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$66.87M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$101.06M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.18M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.79M	shares	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.86M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$5.93M	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Inventory	`InventoryNet`	$11.93M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Inventory	`InventoryNet`	$14.86M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.46M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$118.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$146.77M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.84M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.75M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$5.85M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Total assets	`Assets`	$152.03M	USD	Point-in-time
Total assets	`Assets`	$134.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.65M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$16.34M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$10.41M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$263.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$250.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.88M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.24M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.66M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$35.20M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.60M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$67.04M	USD	Point-in-time
Total liabilities	`Liabilities`	$48.13M	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,791,615 shares and 27,175,305 shares issued and outstanding at December 31, 2021 and 2020, respectively	`CommonStockValue`	$510.49M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,791,615 shares and 27,175,305 shares issued and outstanding at December 31, 2021 and 2020, respectively	`CommonStockValue`	$502.22M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-95.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-188.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-398.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-442.45M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$67.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.89M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$54.65M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$134.89M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$152.03M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$25.64M	USD	Annual
Net revenue	`Revenues`	$30.26M	USD	Annual
Cost of revenue	`CostOfRevenue`	$9.00M	USD	Annual
Cost of revenue	`CostOfRevenue`	$9.10M	USD	Annual
Gross profit	`GrossProfit`	$21.16M	USD	Annual
Gross profit	`GrossProfit`	$16.64M	USD	Annual
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$22.30M	USD	Annual
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$18.83M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$24.19M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$38.28M	USD	Annual
Total operating expenses	`OperatingExpenses`	$60.59M	USD	Annual
Total operating expenses	`OperatingExpenses`	$43.02M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-26.38M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-39.43M	USD	Annual
Interest expense	`InterestExpense`	$3.87M	USD	Annual
Interest expense	`InterestExpense`	$3.98M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-877.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$1.65M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-4.75M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-2.33M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.72M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.18M	USD	Annual
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$32.00K	USD	Annual
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$36.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-28.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-44.22M	USD	Annual
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-1.60	USD	Annual
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-1.16	USD	Annual
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-1.60	USD	Annual
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-1.16	USD	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	24.70M	shares	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	27.62M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.62M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	24.70M	shares	Annual

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-28.75M	USD	Annual
Net loss	`ProfitLoss`	$-44.22M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.58M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.82M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$6.88M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$2.41M	USD	Annual
Non-cash interest and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$540.00K	USD	Annual
Non-cash interest and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$511.00K	USD	Annual
Non-cash lease expense	`NonCashLeaseExpense`	$829.00K	USD	Annual
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$634.00K	USD	Annual
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$1.36M	USD	Annual
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-928.00K	USD	Annual
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$1.06M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$218.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-840.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$4.89M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$1.74M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.15M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$769.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.80M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.09M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$4.88M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.95M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$7.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$60.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$236.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-933.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-28.86M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.27M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$455.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.52M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$72.02M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$121.79M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$80.65M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$104.81M	USD	Annual
Net cash provided by (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$29.27M	USD	Annual
Net cash provided by (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-41.60M	USD	Annual
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$75.67M	USD	Annual
Payments of public offering and other financing costs	`PaymentsOfStockIssuanceCosts`	$705.00K	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$227.00K	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$974.00K	USD	Annual
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$419.00K	USD	Annual
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$357.00K	USD	Annual
Proceeds from Paycheck Protection Program loan	`ProceedsFromPaycheckProtectionProgramLoan`	$2.25M	USD	Annual
Repayment of Paycheck Protection Program loan	`RepaymentOfPaycheckProtectionProgramLoan`	$2.25M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$75.55M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.39M	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$803.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-797.00K	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.49M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$999.00K	USD	Annual
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$3.33M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$3.48M	USD	Annual
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.82M	USD	Annual
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.19M	USD	Annual
Purchases of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.20M	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.58M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.58M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Discounts and issuance costs of stock issued	`DiscountsAndStockIssuanceCosts`	$585.00K	USD	Annual
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$974.00K	USD	Annual
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$227.00K	USD	Annual
Issuance of common stock upon the exercise of common stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	588,461.00	shares	Annual
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$419.00K	USD	Annual
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$357.00K	USD	Annual
Issuance of common stock in public offering, net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$75.08M	USD	Annual
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.41M	USD	Annual
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$6.88M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-46.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-49.00K	USD	Annual
Unrealized losses on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-44.00K	USD	Annual
Unrealized losses on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-47.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-28.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-44.22M	USD	Annual
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-28.75M	USD	Annual
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-44.22M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-46.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-49.00K	USD	Annual
Unrealized losses on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-44.00K	USD	Annual
Unrealized losses on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-47.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-93.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-93.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-28.84M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-44.31M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.